Ströer SE & Co. KGaA Logo

Ströer SE & Co. KGaA

A media company providing integrated out-of-home (OOH) and digital advertising solutions.

SAX | F

Overview

Corporate Details

ISIN(s):
DE0007493991 (+1 more)
LEI:
529900MBF3N1ATE55378
Country:
Germany
Address:
Ströer Allee 1, 50999 Köln
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ströer SE & Co. KGaA is a leading German media company specializing in out-of-home (OOH) advertising, complemented by digital advertising and dialogue marketing. The company provides advertisers with customized, fully integrated marketing solutions through its "OOH plus" strategy, leveraging an extensive portfolio of physical and digital advertising assets, including billboards and street furniture. Ströer's services encompass the entire marketing and sales cycle, offering cross-media campaigns that combine outdoor and online channels. The company also partners with municipalities to integrate its media infrastructure into urban environments, providing public information and cultural services.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 00:00
Investor Presentation
Presentation on the Q3 2025 Statement
English 1.3 MB
2025-09-26 09:52
Director's Dealing
Stroer SE & Co. KGaA: Raquel Falomir, buy
English 6.3 KB
2025-09-18 19:36
Earnings Release
Stroer adjusts outlook for financial year 2025
English 6.8 KB
2025-08-13 00:00
Investor Presentation
Presentation on the Half-year financial report 6M/Q2 2025
English 3.1 MB
2025-08-13 00:00
Interim Report
Half-yearly financial report 2025
English 532.1 KB
2025-08-06 13:14
Report Publication Announcement
English 4.0 KB
2025-07-15 17:48
Major Shareholding Notification
English 14.3 KB
2025-05-08 00:00
Investor Presentation
Presentation on the Q1 2025 Statement
English 4.5 MB
2025-04-24 15:05
Pre-Annual General Meeting Information
Stroer SE & Co. KGaA: Bekanntmachung der Einberufung zur Hauptversammlung am 04…
German 91.4 KB
2025-03-24 00:00
Annual Report
Annual financial report 2024
English 2.8 MB
2025-03-13 00:00
Governance Information
Corporate Governance Declaration (03/13/2025)
English 176.0 KB
2025-03-07 00:00
Investor Presentation
Presentation - Preliminary Figures 2024
English 12.4 MB
2025-03-06 17:15
Report Publication Announcement
English 4.7 KB
2025-03-06 00:00
Investor Presentation
Presentation - Preliminary Figures 2024
English 12.4 MB
2025-03-05 17:15
Report Publication Announcement
English 4.7 KB

Automate Your Workflow. Get a real-time feed of all Ströer SE & Co. KGaA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ströer SE & Co. KGaA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ströer SE & Co. KGaA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-05-10 Müller, Udo Board Other None N/A
2023-12-11 Schmalzl, Christian Board Other None 4,727,202.00 EUR
2023-03-22 APM Media GmbH & Co. KG Close relation Other None 8,000,000.00 EUR
2023-01-25 APM Media GmbH & Co. KG Close relation Other None 6,640,000.00 EUR
2023-01-25 CDXX Vermögens- und Verwaltungs GmbH Close relation Buy None 1,026.00 EUR
2023-01-18 Müller, Maximilian Close relation Buy None 23,600.00 EUR
2023-01-17 NEON Equity AG Close relation Buy None 7,025.00 EUR
2023-01-09 Falomir, Raquel Close relation Buy None 229,950.00 EUR
2022-10-13 Müller, Udo Board Buy None 1,030,913.50 EUR
2022-10-04 Müller, Udo Board Other None 4,000,000.00 EUR

Peer Companies

Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978
RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR
Resolute Holdings Management, Inc. Logo
Asset management firm acquiring and operationally enhancing companies for long-term growth.
United States of America
RHLD
Develops RNA aptamer therapeutics for ophthalmology, pain, fibrosis, and other unmet medical needs.
Japan
4591
Rise Consulting Group, Inc. Logo
Execution-focused consulting for strategy and digital transformation, specializing in JP-CN markets.
Japan
9168
ROQUEFORT THERAPEUTICS PLC Logo
Developing first-in-class, pre-clinical medicines for hard-to-treat cancers.
United Kingdom
ROQ
ROSS GROUP PLC Logo
A holding company in liquidation, formerly providing supply chain management & technology solutions.
United Kingdom
RGP
ROXX, Inc. Logo
HR tech platform connecting non-desk job seekers with full-time roles using AI and vetting tools.
Japan
241A
SAFTEC CO.,LTD. Logo
Rents and sells safety equipment for construction, from basic supplies to AI/IoT solutions.
Japan
7464

Talk to a Data Expert

Have a question? We'll get back to you promptly.